Mindray Medical International Ltd Receives “Hold” Rating from Jefferies Group (MR)
Mindray Medical International Ltd (NYSE:MR)‘s stock had its “hold” rating restated by research analysts at Jefferies Group in a report released on Thursday. They currently have a $32.00 price target on the stock, down from their previous price target of $36.00. Jefferies Group’s target price points to a potential upside of 2.33% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Bank of America downgraded shares of Mindray Medical International Ltd from a “buy” rating to a “neutral” rating in a research note on Wednesday, May 7th. Separately, analysts at Morgan Stanley reiterated an “in-line” rating on shares of Mindray Medical International Ltd in a research note on Tuesday, May 6th. Finally, analysts at Credit Suisse upgraded shares of Mindray Medical International Ltd from an “underperform” rating to a “neutral” rating in a research note on Thursday, April 24th. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $36.30.
Shares of Mindray Medical International Ltd (NYSE:MR) traded up 1.50% on Thursday, hitting $31.74. 144,822 shares of the company’s stock traded hands. Mindray Medical International Ltd has a 52-week low of $29.94 and a 52-week high of $43.81. The stock has a 50-day moving average of $32.24 and a 200-day moving average of $35.27. The company has a market cap of $3.709 billion and a P/E ratio of 18.48.
Mindray Medical International Ltd (NYSE:MR) last announced its earnings results on Monday, May 5th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.02. The company had revenue of $264.80 million for the quarter, compared to the consensus estimate of $292.50 million. During the same quarter in the previous year, the company posted $0.53 earnings per share. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. On average, analysts predict that Mindray Medical International Ltd will post $1.92 earnings per share for the current fiscal year.
Mindray Medical International Limited (NYSE:MR), is a developer, manufacturer and marketer of medical devices worldwide.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.